secwatch.observer — SEC 8-K summary
======================================

Issuer:     CORCEPT THERAPEUTICS INC (CORT)
CIK:        0001088856
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001193125-25-237834
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corcept terminates distribution agreement with Optime Care, effective Jan 8, 2026
--------------------------------------------------------------------------------

- Notice of termination of Distribution Services Agreement with Optime Care given Oct 10, 2025; effective Jan 8, 2026.
- Optime had been specialty pharmacy distributor for Korlym and authorized generic mifepristone.
- Exclusive provider status ended Sept 15, 2025; termination is for convenience under 90-day notice provision.
- Original agreement dated Aug 4, 2017, amended and restated Apr 1, 2024, with term through Mar 31, 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1088856/000119312525237834/0001193125-25-237834-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1088856/000119312525237834/d61706d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-237834

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer